Aarti Drugs Credit Ratings Reaffirmed by CRISIL

CRISIL Limited has reaffirmed the credit ratings for Aarti Drugs Limited’s bank facilities. The long-term rating is reaffirmed at CRISIL AA-/Stable, and the short-term rating is reaffirmed at CRISIL A1+. These ratings apply to total bank loan facilities of Rs. 1,768 Crores.

Credit Ratings Maintained

Aarti Drugs Limited announced that CRISIL Limited has reaffirmed the credit ratings for its bank facilities. This decision reflects CRISIL’s ongoing assessment of the company’s financial stability and performance.

Details of Reaffirmed Ratings

The credit ratings that have been reaffirmed are as follows:

  • Long Term Rating: CRISIL AA-/Stable on facilities amounting to Rs. 1,768 Crores
  • Short Term Rating: CRISIL A1+

Total Facilities Rated

The reaffirmation applies to total bank loan facilities rated at Rs. 1,768 Crores.

Source: BSE

Previous Article

The Great Eastern Shipping Company TDS on Dividend for FY 2025-26

Next Article

One 97 Communications Board Meeting Closure Notification